1,485
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Discovering novel carbonic anhydrase type IX (CA IX) inhibitors from seven million compounds using virtual screening and in vitro analysis

, , &
Pages 425-433 | Received 04 Nov 2014, Accepted 27 Mar 2015, Published online: 07 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Kader Sahin & Serdar Durdagi. (2021) Identifying new piperazine-based PARP1 inhibitors using text mining and integrated molecular modeling approaches. Journal of Biomolecular Structure and Dynamics 39:2, pages 681-690.
Read now
Petar Žuvela, J. Jay Liu, Myunggi Yi, Paweł P. Pomastowski, Gulyaim Sagandykova, Mariusz Belka, Jonathan David, Tomasz Bączek, Krzysztof Szafrański, Beata Żołnowska, Jarosław Sławiński, Claudiu T. Supuran, Ming Wah Wong & Bogusław Buszewski. (2018) Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes. Journal of Enzyme Inhibition and Medicinal Chemistry 33:1, pages 1430-1443.
Read now
Ramin Ekhteiari Salmas, Ayhan Unlu, Muhammet Bektaş, Mine Yurtsever, Mert Mestanoglu & Serdar Durdagi. (2017) Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies. Journal of Biomolecular Structure and Dynamics 35:9, pages 1899-1915.
Read now
Ramin Ekhteiari Salmas, Mine Yurtsever & Serdar Durdagi. (2017) Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism. Journal of Biomolecular Structure and Dynamics 35:4, pages 738-754.
Read now
Belma Zengin Kurt, Fatih Sonmez, Serdar Durdagi, Busecan Aksoydan, Ramin Ekhteiari Salmas, Andrea Angeli, Mustafa Kucukislamoglu & Claudiu T. Supuran. (2017) Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 1042-1052.
Read now
Serdar Durdagi, Neslihan Korkmaz, Semra Işık, Daniela Vullo, Demet Astley, Deniz Ekinci, Ramin E. Salmas, Murat Senturk & Claudiu T. Supuran. (2016) Kinetic and docking studies of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with some hydroxylic compounds. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1214-1220.
Read now

Articles from other publishers (3)

Dušan S. Dimić, Goran N. Kaluđerović, Edina H. Avdović, Dejan A. Milenković, Marko N. Živanović, Ivan Potočňák, Erika Samoľová, Milena S. Dimitrijević, Luciano Saso, Zoran S. Marković & Jasmina M. Dimitrić Marković. (2022) Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives. International Journal of Molecular Sciences 23:2, pages 1001.
Crossref
Agostino Bruno & Gabriele Costantino. 2021. pH-Interfering Agents as Chemosensitizers in Cancer Therapy. pH-Interfering Agents as Chemosensitizers in Cancer Therapy 169 183 .
Shaher Bano Mirza, Ramin Ekhteiari Salmas, M. Qaiser Fatmi & Serdar Durdagi. (2016) Virtual screening of eighteen million compounds against dengue virus: Combined molecular docking and molecular dynamics simulations study. Journal of Molecular Graphics and Modelling 66, pages 99-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.